维普中文期刊产品整合服务
82篇 您的检索式:作者名="Agelakis"
    题名 作者 年代 出处 被引量
1A retrospective analysis of second line chemotherapy or best supportive care in patients with advanced stage non small-cell lung cancer显示文摘Hatzidaki D Agelaki S Mavroudis D 2006Clin Lung Cancer2006,8,1:1
2A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer显示文摘Kouroussis C Agelaki S Mavroudis D 2003Anticancer Res2003,23,1:1
3A dose escalation study of weekly docetaxel in patients with advanced solid tumors显示文摘Kouroussis C Agelaki S Mavroudis D 2000Cancer-Chemother-Pharmacol2000,46,6:1
4A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer 显示文摘Kouroussis C Agelaki S Mavroudis D 2003Anticancer Res2003,23,1:1
5Detection of cy- tokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer 显示文摘Daskalaki A Agelaki S Perraki M 2009Br J Cancer2009,101,4:1
6A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer显示文摘Hatzidaki D Agelaki S Mavroudis D 2006Clin Lung Cancer2006,8,1:1
7Epidermal growth factor re- ceptor inhibitors in the treatment of non-small cell lung cancer 显示文摘Agelaki S Georgoulias V 2005Expert Opin Emerg Drugs2005,10,4:1
8Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer显示文摘Agelaki S G eorgoulias V 2005Expert Opin Emerging Drugs2005,10,4:1
9Corticotropin releasing hormone aguments proinflammatory cytokine production from macrophages in vitro and in Lps-induced exdotoxin shock in mice显示文摘AGELAKIS B TSATSANIS C GRAVANIS A 2002Infect Immun2002,70,11:1
10Amiodarone attenuates ap- optosis,but induces phospholipidosis in rat alveolar epithelial cells 显示文摘E Kapatou A Skyrlas MG Agelaki 2010Journal of physiology and pharmacology2010,61,6:1
11Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice显示文摘Agelaki S Tsatsanis C Gravanis A 2002Infect Immun2002,70,11:1
12Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enha- nces gefitinib-induced tumor cell inhibition 显示文摘Agelaki S Spiliotaki M Markomanolaki H 2009Cancer Biol Ther2009,8,15:1
13Detection of cytokeratin-19 mRNA-pesitive cells in the peripheral blood and bene marrow of patients with operable breast cancer显示文摘Daskalaki A Agelaki S Perraki M 2009Br J Cancer2009,101,4:1
14Pemetrexed (MTA) compared with erlotinib (ERL)in pretreated patients with advanced non-small cell lung cancer(NSCLC):Results of a randomized phase Ⅲ Hellenic Oncology Research Group trial显示文摘Vamvakas L Agelaki S Kentepozidis NK 2010J Clin Oncol2010,28,1:1
15A randomized phase Ⅲ study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic non-small cell lung cancer显示文摘Pallis AG Agelaki S Agelidou A 2010BMC Cancer2010,10,:1
16Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA- positive circulating tumor cells: results of a randomized phase lI study 显示文摘Georgoulias V Bozionelou V Agelaki S 2012Aim Oncol2012,23,7:1
17Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer显示文摘Theodoropoulos PA Polioudaki H Agelaki S 2010Cancer Lett2010,288,1:1
18Phase Ⅰ study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer显示文摘Kosmas C Agelaki S Giannakakis T 2002Oncolagy2002,62,2:1
19Pemetrexed compared with erlotinibin pretreated patients with advanced non-small cell lung cancer Pesults of a randomizad phase lit a Hellenic Oncology Research Group trial显示文摘Vamvakas L Agelaki S Ketepozidis NK 2010J Clin Oncol2010,28,15:1
20A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer 显示文摘Agelaki S Kontopodis E Kotsakis A 2013Cancer Chemother Pharmacol2013,72,1:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费